Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 18, 2015

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Ulcerative Colitis
Trial Locations (23)

T2N 4Z6

University of Calgary /ID# 144032, Calgary

T6G 2X8

Zeidler Ledcor Centre /ID# 145973, Edmonton

V3L 3W5

Columbia Gastro Mgmnt Ltd /ID# 136820, New Westminster

V6Z 2K5

GIRI Gastrointestinal Research Institute /ID# 141107, Vancouver

V8T 5G4

Discovery Clinical Services /ID# 144102, Victoria

V8V 3M9

Percuro Clinical Research, Ltd /ID# 136533, Victoria

E3B 5N5

Dr. Everett Chalmers Reg Hosp. /ID# 136534, Fredericton

E2K 1J5

Dr Chadwick Ian Williams Professional Corporation /ID# 144802, Saint John

L6S 0C1

Bellini Medicine Professional /ID# 144241, Brampton

L1H 1B9

Oshawa Clinic /ID# 144364, Oshawa

K1H 8L6

The Ottawa Hospital /ID# 139392, Ottawa

M53 TA9

Kensington Screening Clinic /ID# 141106, Toronto

M5G 1X5

Mount Sinai Hosp.-Toronto /ID# 141108, Toronto

N8W 1E6

Dr O Tarabain Medicine Prof Corp /ID# 144034, Windsor

N8Y 4C9

Dr. Rahman Bacchus Med. Corp. /ID# 141780, Windsor

G6V 3Z1

Hopital Hotel-Dieu de Levis /ID# 137099, Lévis

H1T 2M4

Hospital Maisonneuve-Rosemont /ID# 137336, Montreal

H2X 3J4

CHUM - Hopital Saint-Luc /ID# 139393, Montreal

H3G 1A4

McGill Univ HC /ID# 136821, Montreal

H3P 3E5

Clinique MEDI-CLE /ID# 153690, Montreal

G1R 2J6

CHU de Quebec-Universite Laval /ID# 147557, Québec

J1H 5N4

CHUS - Hopital Fleurimont /ID# 137840, Sherbrooke

S7N 0W8

Royal Univ. Hosp, Saskatoon,CA /ID# 137838, Saskatoon

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cato Research

INDUSTRY

lead

AbbVie

INDUSTRY